FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study

Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bach, Patrick (VerfasserIn) , Weil, Georg (VerfasserIn) , Pompili, Enrico (VerfasserIn) , Hoffmann, Sabine (VerfasserIn) , Hermann, Derik (VerfasserIn) , Vollstädt-Klein, Sabine (VerfasserIn) , Kiefer, Falk (VerfasserIn) , Mann, Karl (VerfasserIn) , Sommer, Wolfgang H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 April 2021
In: European archives of psychiatry and clinical neuroscience
Year: 2021, Jahrgang: 271, Heft: 5, Pages: 915-927
ISSN:1433-8491
DOI:10.1007/s00406-021-01259-7
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00406-021-01259-7
Volltext
Verfasserangaben:Patrick Bach, Georg Weil, Enrico Pompili, Sabine Hoffmann, Derik Hermann, Sabine Vollstädt-Klein, Falk Kiefer, Karl Mann, Wolfgang H. Sommer
Beschreibung
Zusammenfassung:Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might provide a marker that identifies patients, which benefit from naltrexone treatment.
Beschreibung:Published online: 21 April 2021
Gesehen am 05.12.2022
Beschreibung:Online Resource
ISSN:1433-8491
DOI:10.1007/s00406-021-01259-7